Keywords: protherics, reviews, early, stage, portfolio, uk-based, biopharmaceutical

Protherics reviews early stage portfolio

Article | 04 October 2004

Print This

UK-based biopharmaceutical company Protherics says it has transferred the former Enact Pharma R&D function at Porton Down and out-licensed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in